These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 10863308)
1. [Pathogenesis of HIV infection as the key to eradication? New therapeutic approaches]. Manegold C MMW Fortschr Med; 2000 Mar; 142 Suppl 1():34-9. PubMed ID: 10863308 [TBL] [Abstract][Full Text] [Related]
4. HIV eradication theory meets reality. TreatmentUpdate; 1999 May; 11(3):3. PubMed ID: 11366779 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategies towards HIV-1 infection in macrophages. Perno CF; Svicher V; Schols D; Pollicita M; Balzarini J; Aquaro S Antiviral Res; 2006 Sep; 71(2-3):293-300. PubMed ID: 16806514 [TBL] [Abstract][Full Text] [Related]
6. Current strategies and limitations of HIV vaccines. Kawalekar OU; Shedlock DJ; Weiner DB Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169 [TBL] [Abstract][Full Text] [Related]
7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
8. [Campaign against a chameleon. Therapeutic strategies to control a survival artist]. MMW Fortschr Med; 2000 Mar; 142 Suppl 1():80-1. PubMed ID: 10863320 [No Abstract] [Full Text] [Related]
9. Therapeutic HIV vaccines show promise. Abbott A Nature; 2010 Jul; 466(7306):539. PubMed ID: 20671679 [No Abstract] [Full Text] [Related]
10. HIV type 1 integrase inhibitors: from basic research to clinical implications. Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; QuiƱones-Mateu M AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719 [TBL] [Abstract][Full Text] [Related]
11. Correlates of cytotoxic T-lymphocyte-mediated virus control: implications for immunosuppressive infections and their treatment. Wodarz D; Nowak MA Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1059-70. PubMed ID: 11186307 [TBL] [Abstract][Full Text] [Related]
12. Predictive value of primate models for AIDS. Haigwood NL AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617 [TBL] [Abstract][Full Text] [Related]
13. Outwitting HIV: Minnesota researchers take on a clever virus. Bell H Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268 [No Abstract] [Full Text] [Related]
14. New strategies to combat HIV: augmenting antiviral immunity. Smith KA; Boyle BA AIDS Read; 2003 Aug; 13(8):365-9, 382. PubMed ID: 14524321 [No Abstract] [Full Text] [Related]
15. Clinical implications of HIV dynamics and drug resistance in macrophages. Aquaro S; CaliĆ² R; Balestra E; Bagnarelli P; Cenci A; Bertoli A; Tavazzi B; Di Pierro D; Francesconi M; Abdelahad D; Perno CF J Biol Regul Homeost Agents; 1998; 12(1-2 Suppl):23-7. PubMed ID: 9689575 [TBL] [Abstract][Full Text] [Related]
16. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini. Ho DD J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429 [TBL] [Abstract][Full Text] [Related]
17. [HIV eradication--facts and fiction]. Jaeger H; Wolf E MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923 [No Abstract] [Full Text] [Related]
18. Restoring HIV-specific immunity. James JS AIDS Treat News; 1999 Feb; (No 312):2-6. PubMed ID: 11366200 [TBL] [Abstract][Full Text] [Related]
19. Vaccination against drug resistance in HIV infection. Boberg A; Isaguliants M Expert Rev Vaccines; 2008 Feb; 7(1):131-45. PubMed ID: 18251699 [TBL] [Abstract][Full Text] [Related]
20. Summaries from the Eleventh Annual Houston Conference on AIDS in America. Res Initiat Treat Action; 1999 Jul; 5(3):13-25. PubMed ID: 11366719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]